TGFbeta and Alzheimer's disease

Dr. Richard A. Flavell, Professor of Immunobiology at Yale University School of Medicine,, suggested that cytokine TGFbeta (transforming growth factor beta) could be a target for new drugs to treat Alzheimer's disease (AD). In the following video Dr. Flavell is being interviewed by Dr. Harold Stern, Associate Clinical Professor of Surgery, Yale University School of Medicine, about possible role of TGFbeta in  AD.

Keywords: TGFbeta; Alzheimer's disease; AD; TGFbeta antibodies; TGFbeta antagonists; Richard A. Flavell; Yale Immunobiology; Harold Stern; Targets for antiAlzheimer drugs